Filing Flows › JBT Marel (JBTM) › Q2 2026 › vs Q2 2025
JBT Marel (JBTM) Q2 2026 vs Q2 2025 (year over year)
JBT Marel's revenue rose $46.0M (+5%) from $935M in Q2 2025 to $981M in Q2 2026. The biggest changes: Protein Solutions +$46.0M (+11%); Prepared Food and Beverage Solutions +$0 (0%). Operating margin 4.7% against 5.1% (-0.4 pts).
JBT Marel, Q2 2026: revenue $981M (+5% year over year), operating margin 4.7%, net earnings $28.0M, operating cash flow $102M. The chart draws each line against Q2 2025, the increases inside each band.
Margins
| Q2 2026 | Q2 2025 | Change | |
|---|---|---|---|
| Operating margin | 4.7% | 5.1% | -0.4 pts |
| Net margin | 2.9% | 0.3% | +2.5 pts |
| Free cash flow margin | 7.8% | 9.0% | -1.1 pts |
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Prepared Food and Beverage Solutions | $514M | $514M | $0 | 0% |
| Protein Solutions | $467M | $421M | $46.0M | +11% |
| Revenue | $981M | $935M | $46.0M | +5% |
| Operating profit | $46.0M | $48.0M | −$2.0M | -4% |
| Costs & expenses | $935M | $887M | $48.0M | +5% |
| Pre-tax earnings | $35.0M | $11.0M | $24.0M | +218% |
| Other expense, net | $11.0M | $37.0M | −$26.0M | -70% |
| Net earnings | $28.0M | $3.0M | $25.0M | +833% |
| Income tax | $7.0M | $8.0M | −$1.0M | -12% |
| Share-based compensation | $12.0M | $4.0M | $8.0M | +200% |
| Working capital & other | $62.0M | $96.0M | −$34.0M | -35% |
| Operating cash flow | $102M | $103M | −$1.0M | -1% |
| Free cash flow (OCF − capex) | $77.0M | $84.0M | −$7.0M | -8% |
| Capital expenditures | $25.0M | $19.0M | $6.0M | +32% |
Questions
How much did JBT Marel's revenue grow year over year in Q2 2026?
JBT Marel's revenue rose $46.0M (+5%) from $935M in Q2 2025 to $981M in Q2 2026.
What drove JBT Marel's revenue change in Q2 2026?
Protein Solutions +$46.0M (+11%); Prepared Food and Beverage Solutions +$0 (0%).